FDA Investigator Christina V Santos
Christina V Santos has inspections in 5 countries as of 14 Sep 2023. Christina V Santos has collaborated with a combinined 3054 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Netherlands,
United Kingdom of Great Britain and Northern Ireland,
Germany
Co-Investigator(s):
Ademola O Daramola,
Alicia M Mozzachio,
Amalia C Himaya,
Amalia Himaya,
Angela Jourdain,
Anita Narula, PhD,
Ann Marie Montemurro,
Ann Marie Schofield,
Antonina Aydanian,
Arie C Menachem,
Barbara M Frazier,
Barry Cherney, PhD,
Bichsa T Nguyen,
Bichsa T Tran,
Bo Chi, PhD,
Brenda L Reihing,
Brian D Nicholson,
Brien C Fox,
Bruce H Mccullough,
Bryce E Mansfield,
Burnell M Henry,
Carla J Lundi,
Carrie Ann Plucinski,
Caryn M Mcnab,
Catherine J Laufmann,
CDR Jeremy L Wally, PhD,
Chad R Burger,
Cheron M Portee,
Christian D Lynch (CDL),
Christina A Miller,
Connie Hannon Rabel,
Connie L Hannon Rabel,
Cynthia Jim, CSO,
Daniel W Cline,
David Perkins,
Davinna Ligons, PhD,
Deborah A Nebenzahl,
Debra I Love,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Dolores E Price,
Donna Ltartaglino Besone,
Dr. Guang Gao, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Frances Namuswe, PhD,
Gene D Arcy,
Gerald N Mcgirl, DDS,
Haley H Seymour,
Haley Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Humera Khan,
Iris C Macinnes,
Jacqueline Mdiaz Albertini,
James R Fleckenstein,
Jason F Chancey,
Jay Slater, MD,
Jeanne M Morris,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer L Bridgewater,
Jennifer M Gogley,
Joel Welch, PhD,
Joey V Quitania,
John E Emmert,
John R Myung,
Joyce A Rockwell,
Julie D Bringger,
Jun Park, PhD,
Ka L Wong,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Laura Fontan, MS,
Leonard H Lavi,
Lequita M Mayhew,
Lisa M Bellows,
Lisa M Feola,
Lorelei S Jarrell,
Lori J Silverstein,
Lynda L Perry, PhD,
Madushini Sharmasena, PhD,
Marcia Britt Williams,
Marcus F Yambot,
Margaret M Annes,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Mariza M Jafary,
Mary E Farbman, PhD,
Mary T Carden,
Maxyne T Lam,
Michelle A Marsh,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Mra Davism,
Mra Munizn,
Nancy A Saxenian Emmons,
Nicholas F Lyons,
Nicholas Obiri, PhD,
Nicholas P Diorio,
Nicola M Fenty Stewart,
Nicole J Clausen,
Nicole K Trudel,
Omotunde O Osunsanmi,
Paul M Kawamoto,
Paula A Trost,
Peggy M Speight,
Peter S Diak,
Philip E Ake,
Phung Thien Nguyen,
Prabhu P Raju,
Qiao Y Bobo,
Ralph A Erickson,
Randall N Johnson,
Rebecca K Olin,
Rebecca Rodriguez,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Richmond K Yip,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Darius,
Robert W Jennings,
Rocco C Black,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Lebland,
Rose M Ashley,
Russ R Rivy,
Russell K Riley,
S Lori Brown, PhD MPH,
Sarah Arden,
Scott R Nichols, PhD,
Sean Fitzsimmons,
Sharon I Gundersen,
Shawn E Larson,
Sidney B Priesmeyer,
Simone E Pitts,
Sonia R Peterson,
Stanley Au,
Stephen D Brown,
Steven Fong, MS, PhD,
Susan M Jackson,
Susan P Bruederle,
Susant Hadman,
Taichun Qin, PhD,
Taruna Khurana,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thomas J Arista,
Thomas R Withers,
Thomas Ryan Withers,
Thuy T Nguyen, LCDR,
Todd M Stankewicz,
Uttaniti Limchumroon (Tom),
Xiaojun Yan,
Xiaokuang Lai, PhD,
Yumi J Hiramine,
Yvonne C Wilkes
Christina V Santos's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2000 | FDA 483 | AbbVie Inc. - Form 483, 2000-03-22 |
| July, 2000 | EIR | Organon Teknika B.V. - bioMerieux, BV - EIR, 2000-07-10 |
| June, 2000 | FDA 483 | Organon Teknika b.v. - Form 483, 2000-07-10 |
| November, 2000 | FDA 483 | Alk-abello, Inc. - Form 483, 2000-11-02 |
| March, 2000 | FDA 483 Response | AbbVie Inc. - Form 483R, 2000-04-06 |
| December, 2000 | FDA 483 | ALLERMED LABORATORY, INC. - Form 483, 2000-12-15 |
| March, 2000 | EIR | AbbVie Inc. - EIR, 2000-03-22 |
| February, 2001 | FDA 483 | Amgen, Inc - Form 483, 2001-02-23 |
| February, 2001 | EIR | Amgen, Inc - EIR, 2001-02-23 |
| February, 2000 | EIR | Lonza Biologics, plc - EIR, 2000-02-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more